Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Chinese Journal of Lung Cancer
>
2018
>
21
>
5
Volume:
21
Issue:
5
1. A Case Report of Advanced Lung Adenocarcinoma Harboring KRAS Mutation Treated with Anlotinib.
Page:428—430
2. Advances in Antiangiogenic Treatment of Advanced Non-squamous Non-small Cell Lung Cancer in 2017 ASCO and WCLC.
Page:425—427
3. Research Progress of KRAS Mutation in Non-small Cell Lung Cancer.
Page:419—424
4. Stereotactic Body Radiotherapy for Centrally Located Non-small Cell Lung Cancer.
Page:413—418
5. Analysis of the First Diagnosis Symptom and Its Influencing Factors in 500 Patients with Lung Cancer.
Page:408—412
6. Clinical Analysis of Small Cell Lung Cancer with Bone Marrow Metastases.
Page:403—407
7. Characteristics of Ventricular Function in Pulmonary Hypertension Patients with Different Shape of Interventricular Septum: Preliminary Study with Cardiac Magnetic Resonance Imaging.
Page:397—402
8. Influence of Different Therapies on EGFR Mutants by Circulating Cell-free DNA of Lung Adenocarcinoma and Prognosis.
Page:389—396
9. Correlations between Ape1/Ref-1, ICAM-1 and IL-17A Levels in Serum and Radiation Pneumonitis for Local Advanced Non-small Cell Lung Cancer Patients.
Page:383—388
10. Role of PD 0332991 on the Proliferation and Apoptosis of Vascular Endothelial Cells.
Page:375—382
11. Relationship between FGFR1 Gene Regulation of Circulating Tumor Cells and Clinical Features of Non-small Cell Lung Cancer.
Page:365—374
12. Construction of EZH2 Knockout Animal Model by CRISPR/Cas9 Technology.
Page:358—364
13. Preliminary Study on the Effect of Adipocytes on the Biological Behaviors of Lung Adenocarcinoma A549 Cells in Tumor Microenvironment.
Page:351—357